Marine Natural Products: A Source of Novel Anticancer Drugs
Open accessThe DOI matches its Crossref record; 215 of the 235 references it cites were found in a registry or an index; 37 of the 152 sources its claims cite were checked for support.
Abstract
Cancer remains one of the most lethal diseases worldwide. There is an urgent need for new drugs with novel modes of action and thus considerable research has been conducted for new anticancer drugs from natural sources, especially plants, microbes and marine organisms. Marine populations represent reservoirs of novel bioactive metabolites with diverse groups of chemical structures. This review highlights the impact of marine organisms, with particular emphasis on marine plants, algae, bacteria, actinomycetes, fungi, sponges and soft corals. Anti-cancer effects of marine natural products in in vitro and in vivo studies were first introduced; their activity in the prevention of tumor formation and the related compound-induced apoptosis and cytotoxicities were tackled. The possible molecular mechanisms behind the biological effects are also presented. The review highlights the diversity of marine organisms, novel chemical structures, and chemical property space. Finally, therapeutic strategies and the present use of marine-derived components, its future direction and limitations are discussed.
Overview
CoChat Summary
TL;DR
This review summarizes marine natural products as sources of novel anticancer drugs, covering marine plants, algae, bacteria, actinomycetes, fungi, sponges, and soft corals. It highlights cytotoxic and mechanistic findings, clinical candidates, and chemical property-space diversity, while noting that many marine compounds remain preclinical and the deep sea is largely unexplored.
Key findings
- Marine-derived compounds show anticancer activity across many tumor cell lines: cryptophycin 1 had IC50 = 0.005 and 0.003 ng/mL against KB and LOVO cells; coibamide A had LC50 < 23 nM against NCIH460 lung and mouse neuro-2a cells; salinosporamide A had IC50 = 0.13, 0.28, 7.5, and 35.0 µM against A-549, HL-60, BEL-7402, and P388 cells, respectively.
- The review reports 13 natural products isolated from marine organisms being tested in different phases of clinical trials; examples include bryostatin 1 in phase II, ET-743 in phase I, and dolastatin 10 in phase II. Marine-based drugs cited as used against leukemia, metastatic breast cancer, soft tissue sarcoma, and ovarian cancer include cytarabine, eribulin mesylate, brentuximab vedotin, and trabectidine.
- Marine biodiversity is described as vast: oceans cover over 70% of the earth, nearly 250,000 marine species are described, 99% of all bacteria cannot be cultured, and there are more than 22,000 known microbial secondary metabolites, 70% produced by actinomycetes, 20% by fungi, 7% by Bacillus spp., and 1–2% by other bacteria.
- ChemGPS-NP analysis using eight principal components based on 35 molecular descriptors showed that the reviewed marine compounds did not form tight clusters, indicating chemical diversity within classes such as marine peptides.
Methods
- Narrative review of marine natural products with anticancer activity, emphasizing marine plants, algae, bacteria, actinomycetes, fungi, sponges, and soft corals, and covering in vitro, in vivo, and clinical trial reports.
- For chemical property space, chemical structures were converted to SMILES using Chemsketch and submitted to ChemGPS-NPweb; eight principal component values were obtained from 35 molecular descriptors per compound, and PC1, PC2, and PC3 were plotted in three dimensions.
- Main analysis is qualitative synthesis of reported cytotoxic activities, mechanisms, and clinical status; no systematic search strategy, inclusion criteria, or quantitative meta-analysis is described.
Limitations
- Stated in the paper: sampling difficulties and the need for sufficiently large quantities for detailed analyses; less than 5% of the deep sea has been explored and less than 0.01% of the deep-sea floor sampled in detail; preclinical and clinical data for marine natural compound chemoprevention remain scant; NMR is less sensitive than MS and some compound classes cannot be detected by MS; many compounds such as calothrixins A/B, ulithiacyclamide, patellamide, borophycin, and largazole have not yet entered clinical trials; the exact mechanism of sansalvamide A is unknown.
- Evident from the text: as a narrative review, it lacks a systematic search strategy, formal inclusion/exclusion criteria, risk-of-bias assessment, and quantitative pooling, so the findings are illustrative rather than exhaustive.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
32 Valid · 3 Not valid · 64 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Advanced technology and extensive research on marine natural products have led to the discovery of a new generation of anticancer drugs currently used in clinical trials [6].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 1. Introduction
What the sources say
- Partly supportedcites [6] Ang, 2000, In vivo antimalarial activity of the beta-carboline alkaloid manzamine A, Antimicrob. Agents Chemother. sourceExperimental — accuracy not yet measured
The Abstract (page not specified) says marine-sponge manzamines had attracted interest as potential anticancer agents and inhibited cancer-cell growth. It does not say that advanced technology produced a new generation of anticancer drugs or that any were in clinical trials; this paper reports antimalarial testing in mice. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Natural bioactive molecules exhibit cytotoxic effects by attacking macromolecules expressed by cancer cells, such as those in oncogenic signal transduction pathways [16].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 1. Introduction
What the sources say
- Supportedcites [16] Nobili, 2009, Natural compounds for cancer treatment and prevention, Pharmacol. Res. source
The Conclusions describe natural compounds with cytotoxic activity that target macromolecules in cancer cells, including compounds targeting oncogenic signal-transduction pathways. The citing sentence paraphrases that distinction. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Over the past 50 years, emerging evidence has shown that many natural products derived from plants and microbes of marine origin (Table 1), exhibit beneficial effects in the prevention and treatment of cancer, i.e., cytarabine, eribulin mesylate, brentuximab vedotin, and trabectidine are marine-based drugs used against leukemia, metastatic breast cancer, soft tissue sarcoma and ovarian cancer [20,”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 2. Nature and Cancer Chemotherapy
What the sources say
- Partly supportedcites [20] Dyshlovoy, S.A., and Honecker, F. (2018). Marine compounds and cancer: 2017 updates. Mar. Drugs, 16. sourceExperimental — accuracy not yet measured
The paper’s main text reports anticancer activity in compounds from marine algae and microbes and identifies four marine-derived drugs approved to treat cancer. It does not establish beneficial effects in cancer prevention, so the prevention portion of the claim is unsupported. (LLM, conf=0.85)
- Not matchedcites [21] (2019, August 17). Drug Bank. Available online: http://www.drugbank.ca.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The bryostatin 1 has recently entered phase II clinical trial against melanoma, non-Hodgkin’s lymphoma, renal cancer and colorectal cancer [58,59,60].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs
What the sources say
- Not checked — no full text of the sourcecites [58] Bourhill, 2017, Enzastaurin: A lesson in drug development, Crit. Rev. Oncol. Hematol. source
- Partly supportedcites [59] Wang, 2013, Marine-derived angiogenesis inhibitors for cancer therapy, Mar. Drugs sourceExperimental — accuracy not yet measured
Section 4.1 reports phase I and II bryostatin-1 trials involving all four named cancers, and the References list phase II studies for each, including colorectal cancer (ref. 132). But the paper says more than 80 phase I and II trials had been conducted since 1993; it does not support the claim that bryostatin-1 had recently entered phase II trials. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [60] Ritchie, 2015, Cancer research UK centre for drug development: Translating 21st-century science into the cancer medicines of tomorrow, Drug Discov. Today source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Based on modern research, cultured benthic cyanobacteria from temperate marine environments provide a promising, under-exploited source for novel drugs against leukemia [107].”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
What the sources say
- Could not verifycites [107] Peng, 2010, Structure and absolute configuration of karlotoxin-2, an ichthyotoxin from the marine dinoflagellate Karlodinium veneficum, J. Am. Chem. Soc. sourceExperimental — accuracy not yet measured
The Abstract describes karlotoxin-2 from the marine dinoflagellate Karlodinium veneficum and its toxicity to fish. Searches for benthic cyanobacteria and leukemia found no passage addressing their potential as a source of leukemia drugs. (LLM, conf=0.77)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Could not verify
69 more claims · 15 with their cited sources checked
Create a free account to see all 110 claims and to verify the 12 references still open.
- It may state two separate claims as one. 23
- Probably not a substantial claim. 18
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
“against KB cells and 5 µg/mL against LOVO cells (colon cancer)”
§ Marine Natural Products: A Source of Novel Anticancer Drugs > 5. From Marine Organisms to Anticancer Drugs > 5.1. Marine Plants
“against human epidermoid carcinoma (LOVO) and human colorectal adenocarcinoma (KB) cell lines”
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 2×
“In 2018, approximately 18 million new cases of cancer reported globally, resulting in approximately 10 million deaths [1].”
BackgroundCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Prokaryotes: The unseen majority
Whitman, W. B., Coleman, D. C., & Wiebe, W. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6578 · Cited by 4,871
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687 · cited 2×
“Approximately 80% of the approved chemotherapeutic drugs [13], and more than half of all drugs are based on bioactive natural products [14].”
BackgroundBioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170 · cited 1×
“Of these actinomycete-derived compounds, 75% were derived from Streptomyce whereas 25% were derived from rare actinomycetes [125,126].”
BackgroundNatural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082 · cited 1×
“Approximately 80% of the approved chemotherapeutic drugs [13], and more than half of all drugs are based on bioactive natural products [14].”
BackgroundMedicinal plants: Traditions of yesterday and drugs of tomorrow
Gurib-Fakim, A. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.008 · Cited by 2,391 · cited 1×
“The incidence of cancer continues to increase due to environmental changes and life style modernization [3].”
BackgroundShahidi, F., Janitha, P. K., & Wanasundara, P. D. (1992) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408399209527581 · Cited by 2,238
Research works printed but not linked: 7
- Whitman, 1998, The unseen majority, Proc. Natl. Acad. Sci. USA, 74, 5088
- Reyes, 2002, The marine pharmacy: New antitumoral compounds from the sea, Pharm. News, 9, 495
- Laatsch, H. (2011). AntiBase 2011: The Natural Compound Identifier, Wiley-Vch.
- Harmon, 2000, Ecteinascidin-743 (et-743) induces objective responses and disease control in patients with advanced non-osseous sarcomas: Results from phase Ii trials, Ann. Oncol., 11, 126
- Lavakumar, 2012, Anticancer and antioxidant effect of Acanthophora spicifera against EAC induced carcinoma in mice, J. Pharm. Res., 5, 1503
- Suja, 2014, Anticancer activity of compounds isolated from marine endophytic fungus Aspergillus terreus, World J. Pharm. Pharm. Sci., 3, 661
- Devi, 2015, Molecular modeling, quantitative structure activity relationship and pharmacophore studies on antiǧviral, antiǧmalarial and antiǧinflammatory bioactive compounds from marine sources, Asian J. Pharm. Clin. Res., 8, 36
Cited by
Items 301–400 of 551
Premarathna, A. D., Rjabovs, V., Humayun, S., Darko, C. N. S., Robal, M., Ahmed, T. A., Hincke, M. T., & Tuvikene, R. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141793 · Cited by 9
Yang, C.-W., Chien, T., Yen, C., Wu, W., Sheu, J., & Chang, H. (2022) · Pharmaceuticals · doi:10.3390/ph15080917 · Cited by 7
Sánchez‒Ramos, M., Encarnación‒García, J. G., Marquina‐Bahena, S., Sánchez‐Carranza, J. N., Bernabé‐Antonio, A., Domínguez-Villegas, V., Cabañas-García, E., & Cruz‐Sosa, F. (2023) · Pharmaceuticals · doi:10.3390/ph16101400 · Cited by 8
Secondary metabolites from marine epiphytic bacteria against plant pathogens
Younas, H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95251-4.00012-0 · Cited by 10
Eom, S. H., Hong, G.-L., Kang, H. B., Lee, N., Kim, D. K., Jeong, Y., Kim, C., Yoo, Y. C., Lee, B. H., Jung, J., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45100531 · Cited by 6
Lee, S.-G., Park, C.-H., & Kang, H. W. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112621 · Cited by 7
“Given the rich biodiversity and abundant sources of bioactive compounds in marine environments, considerable efforts have been made to explore functional components from marine algae [21,22].”
BackgroundMethodMendoza, M. F. M., Mota, J. A., de Oliveira, F. D. C. E., Cavalcanti, B. C., Turco, J. F., Torres, Y. R., Ferreira, P. M. P., Nepomuceno, F. W. A. B., Rocha, D. D., Pessoa, C., et al. (2024) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2024.2308256 · Cited by 6
“Although drug synthesis and drug repurposing are currently of interest, natural product extracts have been and still constitute an important starting point for the discovery and development of new drug candidates (Atanasov et al. 2021; Hong, Luo, and Lei 2020; Khalifa et al. 2019).”
BackgroundLi, G., Chang, X., Luo, X., Zhao, Y., Wang, W., & Kang, X. (2021) · PubMed Central · doi:10.12122/j.issn.1673-4254.2021.06.21 · Cited by 6
“[14]Khalifa SAM, Elias N, Farag MA, et al.”
BackgroundIn silico and in vitro approaches to evaluate the bioactivities of Chaetomorpha linum
Gayathiri, E., Mahalakshmi, P., Pratheep, T., Prakash, P., Selvam, K., Manivasagaperumal, R., Ragunathan, M. G., Jayanthi, J., & Kumaravel, P. (2022) · South African Journal of Botany · doi:10.1016/j.sajb.2022.06.067 · Cited by 6
Calculation of binding affinity of JAK1 inhibitors via accurately computational estimation
Le, T.-T.-H., Tran, L. H., Nguyen, M. T., Pham, M. Q., & Phùng, H. T. T. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2118830 · Cited by 6
“The LIE model (Khalifa et al., 2019; Wu et al., 2015, 2018) is an approximation approach that finds a match between CPU computational demand and required accuracy.”
BackgroundNon-coding RNA-related antitumor mechanisms of marine-derived agents
Zhou, Z., Cao, Q., Diao, Y., Wang, Y., Long, L., Wang, S., & Li, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1053556 · Cited by 6
Wang, D., Jiang, W., Churiwal, M., Jia, K., Senadeera, S. P. D., Bokesch, H. R., Woldemichael, G. M., Kim, Y. Y., Hawley, R. G., Wei, J. S., et al. (2024) · Journal of Natural Products · doi:10.1021/acs.jnatprod.3c01041 · Cited by 6
Ramya, S., Manivannan, H. P., Veeraraghavan, V. P., et al. (2024) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_570_23 · Cited by 5
Murakami, R., Mori, T., Murata, K., et al. (2024) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.4c02707 · Cited by 5
Ueoka, R., Shinzato, N., Kagaya, N., et al. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-00377-z · Cited by 5
Cytotoxic and Antimicrobial Activities of Quinones Isolated from Different Organism
Campos‐Xolalpa, N., Pérez‐Ramos, J., Esquivel-Campos, A. L., Pérez‐González, C., Sánchez‐Pérez, L., & Pérez‐Gutiérrez, S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95598 · Cited by 7
“In 2018, there were reported about 18 million new cases of cancer [1] and approximately 9.”
BackgroundWeiland‐Bräuer, N., Saleh, L., & Schmitz, R. A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2795-2_3 · Cited by 5
Exploring marine Lactobacillus and its protein for probiotic-based oral cancer therapy
Vidya, S. L., Thiruneelakandan, G., Krishnamoorthy, R., Subbarayan, S., Maran, B. A. V., Alshuniaber, M. A., Gatasheh, M. K., Sunday, B. Y., & Ahmad, A. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127652 · Cited by 8
Fight for Cancer Diseases using Natural Compounds and Their Semisynthetic Derivatives
Kurniawan, Y. S., Gurning, K., Iksen, I., & Bikharudin, A. (2024) · Bioactivities · doi:10.47352/bioactivities.2963-654x.221 · Cited by 6
Marine anticancer drugs in modulating miRNAs and antioxidant signaling
Chuang, Y.-T., Yen, C., Tang, J., Wu, K., Chang, F., Tsai, Y., Chien, T., & Chang, H. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111142 · Cited by 6
Self-citationClinically tested marine mollusk-derived anticancer agents: Chemico-pharmacological aspects
Sasikumar, P., Aparna, V., Sebastian, A. T., Muneer, A., Prabha, B. S., Lailakumari, V. C., & Ijinu, T. P. (2024) · Studies in natural products chemistry · doi:10.1016/b978-0-443-22214-6.00021-1 · Cited by 5
Selvaraj, C., Rajendran, S., Alothaim, A. S., Vijayakumar, R., Desai, D., Safi, S. Z., & Singh, S. K. (2025) · Chemical Papers · doi:10.1007/s11696-025-04007-6 · Cited by 8
Anticancer natural product from marine invertebrates
Singh, R. K., Ranjan, A., Singh, M., & Srivastava, A. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821710-8.00011-4 · Cited by 5
de Oliveira, J. T., Franco, F. N., Tecchio, K. B., et al. (2020) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2020.503294 · Cited by 5
Wijianto, B., Hamzah, H., Nurhidayah, A. L., et al. (2022) · Borneo Journal of Pharmacy · doi:10.33084/bjop.v5i1.2936 · Cited by 5
From the Sea for the Sight: Marine Derived Products for Human Vision
Brillante, S., Galasso, C., Lauritano, C., & Carrella, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.892764 · Cited by 7
Organic extract of Geodia cydonium induces cell cycle block in human mesothelioma cells
Meo, F. D., Esposito, R., Cuciniello, R., Favale, G., Arenga, M., Ruocco, N., Nuzzo, G., Fontana, A., Filosa, S., Crispi, S., et al. (2022) · Oncology Letters · doi:10.3892/ol.2022.13406 · Cited by 5
“Natural marine compounds are known to exert anticancer activity in vitro and in vivo (33,34), as well as in clinical settings (35), by acting on the cell cycle (36).”
BackgroundTwo new mohangic acid derivatives from the deep-sea bacteria Alcanivorax dieselolei BC-5
Zhao, H.-W., Yi, Y., Li, J., et al. (2022) · Natural Product Research · doi:10.1080/14786419.2022.2112578 · Cited by 5
“Marine organisms under extreme growth conditions are considered to be largely unexplored natural resources, with great potential to produce novel and unique natural products (Li and Lou 2018) (Khalifa et al. 2019).”
BackgroundBlue marine therapy: Sea as a trove of natural anticancer drugs
Bettio, D., Page, G., & Thoreau, V. (2023) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2023.06.001 · Cited by 5
Permatasari, H. K., Bdira, S. B., Moon, M., Amalia, N., Sulistomo, H. W., Riawan, W., Choi, J., Chung, S., Park, M. N., Seo, B.-K., et al. (2023) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2023.100796 · Cited by 8
Reis, M. B. E., Maximo, A. I., Magno, J. M., Bellan, D. D. L., Buzzo, J. L. A., Simas, F. F., Rocha, H. A. O., Trindade, E. D. S., & de Oliveira, C. C. (2024) · Marine Biotechnology · doi:10.1007/s10126-024-10287-y · Cited by 5
“In fact, marine flora has been used for medicinal purposes since ancient times, and nowadays, many marine organisms such as microalgae, macroalgae (seaweeds), sponges, and tunicates have already been studied for cancer treatment (Khalifa et al. 2019).”
Sruthi, S. N., Basha, S. A., Kumaran, K., Macrin, D., Mythili, V. M. R., & ArulJothi, K. N. (2024) · Current Bioactive Compounds · doi:10.2174/0115734072296835240409124751 · Cited by 4
Nazemi, M., Golshan, M., Khaledi, M., Shushizadeh, M. R., Zare, M., Moradipoodeh, B., & Jenabidehkordi, K. (2024) · Jundishapur Journal of Natural Pharmaceutical Products · doi:10.5812/jjnpp-147745 · Cited by 4
Liu, Y., Lu, T., Li, R., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-75205-7 · Cited by 4
Pradeepa Kumar, C., Banumathi, Satyanarayan, N. D., Prasad, S. R., Achur, R. N., & Prabhakar, B. T. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03830-8 · Cited by 9
“Recent research has made enormous progress in the development of synthetic and natural substances for the treatment of cancer (Mimeault and Batra 2011; Nautiyal et al. 2011; Khalifa et al. 2019).”
Evaluation of cytotoxic activity of marine fungi isolated from sponges in Nha Trang bay
Thi, H. T. P., Yurchenko, E. A., Yurchenko, A. N., et al. (2022) · Vietnam Journal of Marine Science and Technology · doi:10.15625/1859-3097/16631 · Cited by 4
Ecological and environmental services of microalgae
Sharma, A., & Arya, S. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91869-5.00007-7 · Cited by 8
Anticancer and Antimutagenic Properties of Pogonatherum paniceum on Colorectal Cancer Cells
Praphasawat, R., Thakaew, S., Rawangkan, A., et al. (2023) · World Journal of Oncology · doi:10.14740/wjon1602 · Cited by 4
“The World Health Organization (WHO) has estimated that approximately 75-80% of the world’s population depends mainly on traditional medicines for their health care [14, 15].”
BackgroundWu, C., Murakami, M., Li, Y.-C., Huang, Y.-H., Chang, Y., Hung, T., Wu, Y., & Ambudkar, S. V. (2023) · Pharmaceuticals · doi:10.3390/ph16111595 · Cited by 5
Qiu, H., Qian, S., Head, S. A., et al. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129741 · Cited by 4
An Assessment of Marine Natural Pigments for Medicinal Potency
Devliya, B., Patel, B., Prajapati, A., & Patel, H. D. (2024) · Thalassas An International Journal of Marine Sciences · doi:10.1007/s41208-024-00707-0 · Cited by 4
“Marine floras, such as cyanobacteria, mangroves, fungi, microalgae, seaweeds, bacteria, actinobacteria, and other halophytes are extremely important marine resources, constituting over 90% of the marine biomass (Khalifa et al. 2019).”
Hardhiyuna, M., Arbi, U. Y., Zuraida, Z., & Ahmadi, P. (2024) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2024.25.5.1737 · Cited by 6
“Secondary metabolite extracts from sponges contain bioactive compounds that act as cytotoxic and antitumors [12].”
BackgroundRen, Q., Chen, G., Wan, Q., Xiao, L., Zhang, Z., & Feng, Y. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107860 · Cited by 5
Hyrtios sp.-associated Cladosporium sp. UR3 as a potential source of antiproliferative metabolites
Abdelhafez, O. H., Elmaidomy, A. H., Hisham, M., Glaeser, S. P., Kämpfer, P., Wu, J., & Abdelmohsen, U. R. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03560-6 · Cited by 5
“These tremendous efforts had led to the discovery of a great number of anticancer drugs [12].”
BackgroundLi, N., Xu, J., Li, Y., Elango, J., & Wu, W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051869 · Cited by 4
“With the advancement of research on marine biological resources, marine organisms have emerged as a vital source for the development of novel drugs and functional materials, owing to their unique biological environment and abundance of bioactive molecules [1–3].”
Shiau, J., Yang, C.-W., Liu, W., Yu, S., Yen, C., Chang, F., Sheu, J., & Chang, H.-W. (2025) · BMC Cancer · doi:10.1186/s12885-025-14276-9 · Cited by 4
Self-citationMarine derivatives prevent E6 protein of HPV: An in silico study for drug development
Quân, P. M., Anh, H. B. Q., Hang, N. T. N., et al. (2022) · Regional Studies in Marine Science · doi:10.1016/j.rsma.2022.102619 · Cited by 4
Current Status of Commercial Anticancer Phytochemicals and Their Derivatives
Mehta, N., Mehta, K., & Saini, R. K. (2022) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5129-8.ch008 · Cited by 4
Anticancer Potential of Three Sea Cucumber Species Extracts on Human Breast Cancer Cell Line
Santhanam, R. K., Azam, N. S. M., Khadar, A. S. A., Louise, A., Dominic, G., Sofian, N. S. A., Han, S. W., Karunakaran, T., Nagappan, T., Muhammad, T. S. T., et al. (2022) · SQUALEN Bulletin of Marine and Fisheries Postharvest and Biotechnology · doi:10.15578/squalen.669 · Cited by 4
Liu, Y., Lin, L., Zheng, H., He, Y., Li, Y., Zhou, C., Hong, P., Sun, S., Zhang, Y., & Qian, Z. (2023) · Marine Drugs · doi:10.3390/md21030156 · Cited by 4
Xing, H., Zhu, X., Liao, J., Kong, Y., Lu, Y., Zhao, D., Li, N., Chen, X., & Qin, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1109084 · Cited by 4
Reddy, T. S., Rai, S., & Koppula, S. K. (2023) · Polycyclic aromatic compounds · doi:10.1080/10406638.2023.2259563 · Cited by 4
Spongia Sponges: Unabated Sources of Novel Secondary Metabolites
Yang, Q., & Liang, L. (2024) · Marine Drugs · doi:10.3390/md22050213 · Cited by 4
“They are frequently developed as lead compounds and drugs [2,3], such as for anticancer [4,5], antimalarial [6], and human immunity purposes [7].”
Fluorescent dyes for the study of siliceous sponges
Danilovtseva, E. N., Pal’shin, V. A., Zelinskiy, S. N., et al. (2019) · Limnology and Freshwater Biology · doi:10.31951/2658-3518-2019-a-5-302 · Cited by 4
Microbial Production of Antimicrobial and Anticancerous Biomolecules
Indira, M., Venkateswarulu, T. C., Krupanidhi, S., & Peele, K. A. (2021) · Wiley eBooks · doi:10.1002/9781119717317.ch8 · Cited by 4
Galal‐Khallaf, A., Shetaia, A. A., Khalifa, S. A. M., Zou, X., Sakr, H. H., Chen, L., Shehata, A. A., Guo, Z., El-Seedi, H. R., & Mohammed-Geba, K. (2022) · Research Square · doi:10.21203/rs.3.rs-2143204/v1 · Cited by 4
Self-citationNatural Products to Cure Bad Breath
Khan, K. M., Hameed, S., & Shamim, S. (2023) · Wiley eBooks · doi:10.1002/9781394167197.ch12 · Cited by 5
Niu, S., Huang, S., Shi, M., Luo, Z.-H., Shao, Z., Hong, B., & Tian, W. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108311 · Cited by 3
Chang, Y., Shen, S., Zhang, L., et al. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500114 · Cited by 3
“MNPs have long served as a valuable source for drug discovery, owing to their unique chemical structures and exceptional biological activities [37].”
Anticancer Activity of Natural Compounds
Jan, I., Ali, T., Khaki, P. S. S., Feroz, A., Andrabi, K. I., & Bader, G. N. (2025) · Springer eBooks · doi:10.1007/978-981-96-4379-0_6 · Cited by 4
Marine Natural Products as Drug Leads: A Recent Overview of Bioactivity and Mechanistic Insights
Xue, J., & Lu, Y. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500970 · Cited by 4
“In cancer therapy, these products present a variety of distinct mechanisms of action and molecular targets, thereby facilitating the development of novel anticancer drugs [130].”
Souresh, V., Srikayalsamyukktha, M., Harini, M., Saravanan, Y., & Saravanakumar, R. (2025) · The Protein Journal · doi:10.1007/s10930-025-10289-2 · Cited by 3
“Among these, marine-derived cyclic peptides have gained significant attention due to their unique structural features and strong biological activities [50].”
George, M. R. P., Elsadek, L. A., Deering, M., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202523117 · Cited by 3
Marine Resources for Marine-Derived Drugs: A Review
Supanekar, S. P., Naik, M. S., & Varun, S. (2024) · UTTAR PRADESH JOURNAL OF ZOOLOGY · doi:10.56557/upjoz/2024/v45i53943 · Cited by 3
Protective Role of Ovothiol-A against Muscle and Kidney Injuries in Obese Rats
Arafa, N. H., Shehata, M. R., & Mohamed, A. S. (2024) · Current Chemical Biology · doi:10.2174/0122127968306623240830071012 · Cited by 3
Linani, A., Bensenouci, S., Hafsa, B. L., Benarous, K., Serseg, T., Bou-Salah, L., & Alhatlani, B. Y. (2024) · Applied Sciences · doi:10.3390/app14209306 · Cited by 3
Laadraoui, J., Kabdy, H., Oufquir, S., Aitlarradia, M., Agouram, F., Aitbaba, A., Oubella, K., & El‐Mansoury, B. (2025) · IGI Global eBooks · doi:10.4018/979-8-3693-9112-9.ch005 · Cited by 4
New Bioactive Eudesmane‐type Sesquiterpenoids From the Red Sea Soft Coral Nephthea sp.
Eissa, A. H., Aboseada, H. A., & Ayyad, S.-E. N. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202502473 · Cited by 3
Crambescidin Acid from the French Polynesian Monanchora n. sp. Marine Sponge
El‐Demerdash, A., Petek, S., Debitus, C., et al. (2020) · Chemistry of Natural Compounds · doi:10.1007/s10600-020-03262-1 · Cited by 3
Marine Microorganisms: From Pollutant Degradation to Added Value Products
Ameén, F., Tami, M. S. A., Alsamhary, K. I., & Zuo, P. (2022) · Microorganisms for sustainability · doi:10.1007/978-981-16-4574-7_10 · Cited by 3
Usami, Y., Mizobuchi, Y., Ijuin, M., Yamada, T., Morita, M., Mizuki, K., Yoneyama, H., & Harusawa, S. (2022) · Marine Drugs · doi:10.3390/md20070438 · Cited by 3
Endres, C. T., Rigo, G. V., Loges, L. A., Landell, M. F., Silva, D. B., Macêdo, A. J., & Tasca, T. (2022) · Marine Biotechnology · doi:10.1007/s10126-022-10164-6 · Cited by 4
“The need to produce secondary metabolites as a defense tool to survive in extreme environments, temperature, salinity, pressure, and resistance to predators, makes marine organisms offer this chemical and pharmacological arsenal (Khalifa et al. 2019) which is gradually being discovered.”
BackgroundStreptomyces spiramenti sp. nov., isolated from a deep-sea microbial mat
Loughran, R. M., Diefendorf, C. M., Reill-VanSise, J. R., Mitchell, E. A. D., Vining, O. B., Gallegos, D. A., Miller, G., Koyack, M. J., Oline, D. K., Rivers, O. S., et al. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-03326-6 · Cited by 3
The cytotoxic activity of Sponges and Tunicates from Turkish Aegean Sea
Uras, İ. S., Mutlu, B., Çakır-Koç, R., et al. (2022) · Indian Journal of Geo-Marine Sciences · doi:10.56042/ijms.v51i09.2335 · Cited by 3
Iskandar, M., Ruiz-Houston, K. M., Bracco, S. D., Sharkasi, S. R., Villarroel, C. L. C., Desai, M., Gerges, A., Lopez, N. A. O., Barbero, M. X., German, A. A., et al. (2023) · Marine Drugs · doi:10.3390/md21120615 · Cited by 2
“Future advancements are needed”
Effects of Potential Prebiotics from Codium fragile on Intestinal Diseases
Oh, S. W., Kim, S. K., Ahn, B. J., Yim, S.-K., & Yang, S. H. (2024) · Applied Sciences · doi:10.3390/app14073037 · Cited by 2
Germoush, M. O., Fouda, M. M. A., Aly, H. A. A., et al. (2024) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2024.100375 · Cited by 3
Lu, J., Liang, W., Hu, Y., Zhang, X., Yu, P., Cai, M., Xie, D., Zhou, Q., Zhou, X., Liu, Y., et al. (2024) · Natural Products and Bioprospecting · doi:10.1007/s13659-024-00455-x · Cited by 3
“Marine natural products, in particular, have shown great potential in fighting cancer with minimal harm to healthy cells, making them a promising and sustainable source of medicines [10].”
BackgroundMarine-Derived Materials for the Development of Advanced Drug Delivery Systems
Eğe, H., Eğe, Z. R., & Gündüz, O. (2024) · Springer eBooks · doi:10.1007/978-3-031-56363-8_55 · Cited by 4
Jeevithan, L., Diao, X., Hu, J., Elango, J., Wu, W., de Val, J. E. M. S., Rajendran, S., Sundaram, T., & Sekar, S. K. R. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1422648 · Cited by 3
Development of a full ocean depth hydraulic manipulator with heavy-duty capacity
Ruan, D., Chen, J., Peng, X., & Ai, J. (2024) · Frontiers in Marine Science · doi:10.3389/fmars.2024.1470361 · Cited by 5
Natural Compounds and Cancer: Current Evidences
Lianou, A. D., Lianos, G. D., Schizas, D., Machairas, N., Mitsis, M. C., & Alexiou, G. Α. (2024) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2024.19.3.621 · Cited by 4
Marine life as a source of anti-prostate cancer agents: an updated overview (2003–2023)
Hussain, A., Sohail, A., Akash, M. S. H., Iqbal, S., Rehman, K., Imran, M., Khan, S., Ayub, M. A., Wang, D., Ahmed, D., et al. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03886-6 · Cited by 3
Zooplankton biomass as a promising new agent for biomedical applications
Abo-Taleb, H. A. H., Khattab, A. M., Bashar, M. A. E., Mehany, A. B. M., Abdelaziz, A. M., Abu‐Elghait, M., & El‐feky, M. M. M. (2025) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2025.103560 · Cited by 3
Enhancing cancer treatment with marine algae–derived bioactive chemicals: a review
Parveen, B., & Narayanan, M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04432-0 · Cited by 4
“…chemicals, sourced from natural entities like plants, and marine organisms, as well as microbes, demonstrate anti-cancer effects via multiple methods, such as cell cycle arrest, apoptosis induction, angiogenesis suppression, and signaling pathway regulation (Khalifa et al. 2019; Narayanan 2024).”
Hamid, T. H. T. A., & Rosmadi, A. (2020) · European Journal of Biology and Biotechnology · doi:10.24018/ejbio.2020.1.5.87 · Cited by 3
“Marine invertebrates have been the largest contributors to marine bioactive compound production and these compounds have shown high incidence of cytotoxicity [3].”
BackgroundMuhamadali, H., Simoens, K., Yun Xu, A., Nicolaï, B. M., Bernaerts, K., & Goodacre, R. (2020) · Metabolites · doi:10.3390/metabo10090379 · Cited by 2
“are unique amongst the bacteria as they form filamentous mycelia and secrete a large number of natural products (NPs) including hydrolytic enzymes and secondary metabolites with key pharmaceutical and industrial applications [1], such as antibacterial molecules [2], anticancer agents [3], immunosuppressants [4], and i…”
BackgroundZhong, F., Yang, Y. B., Ren, D.-W., Long, S., Qin, X., Liu, J., Zeng, Y., Lan, W., Ma, W., & Liu, W. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10173 · Cited by 3
“Marine organisms live in a special environment of low oxygen, high pressure and high salt, and their metabolites may have clinically relevant biological activities (28).”
BackgroundBiotechnology of Nanostructures Micronutrients Vitamins for Human Health
Madkour, L. H. (2021) · Journal of Biomedical Research & Environmental Sciences · doi:10.37871/jbres1243 · Cited by 3
“Plant extracts [5,6] chemical stability, sensory”
(2022) · Jordan Journal of Biological Sciences · doi:10.54319/jjbs/150309 · Cited by 3
Kalaimathi, K., Shine, K., Gandhi, G. R., Vijayakumar, S., Ayyanar, M., Amalraj, S., Varatharaju, G., Thiruvengadam, M., Ceasar, S. A., Prabhu, S., et al. (2023) · Intelligent Pharmacy · doi:10.1016/j.ipha.2023.06.002 · Cited by 6
Bargaining and Argument-Based Negotiation: .
Rahwan, I., Sonenberg, L., & McBurney, P. (2004) · Cited by 4
Freitas, H. P. S., Silva, F. C. O., Ferreira, M. K. A., de Menezes, J. E. S. A., dos Santos, H. S., da Fonseca, A. M., Nogueira, C. E. S., Marinho, M. M., Marinho, E. S., Teixeira, A. M. R., et al. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2193988 · Cited by 2
“…as the actinomycetes, especially those of the genus Streptomyces , are producers of secondary metabolites with a broad spectrum of biological activities, including anti-cancer, antibacterial, antimalarial and antitubercular (Cheng et al., 2016; Khalifa et al., 2019; Liang et al., 2020).”
BackgroundLee, E.-G., Yim, S.-K., Kang, S., Ahn, B. J., Kim, C., Lee, M., Tark, D., & Lee, G.-H. (2025) · Medicina · doi:10.3390/medicina61010165 · Cited by 3
Zheng, Y., Zhang, H., Yin, H., Jia, J. M., Liu, X., & Wang, C. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500901 · Cited by 4
Ma, C., Ouyang, H., Feng, J., Wang, Z., & Jin, G. (2025) · Journal of Saudi Chemical Society · doi:10.1007/s44442-025-00031-z · Cited by 3
“Cancer poses an enormous burden on global health, and the serious side effects of currently available cancer treatments have led people to focus on natural products [1–3].”
Narayanan, M., & Rajinikanth, V. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00517-7 · Cited by 4
Wang, S., Wang, G., Chen, N., et al. (2025) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00538 · Cited by 2
Chen, J., Cui, H., Wang, X., Zeng, Y., Pan, D., Chen, J., Zhang, Z., An, Y., Gu, Z., Cai, G., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07323-3 · Cited by 2
de Almeida, P. D. O., Bozorgzadeh, S. A., de silva, L. A., et al. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100943 · Cited by 2
Metadata
- Authors
- Khalifa, S. A. M., Elias, N., Farag, M. A., Chen, L., Saeed, A., Hegazy, M.-E. F., Moustafa, M. S., Abd El-Wahed, A., Al-Mousawi, S. M., Musharraf, S. G., Chang, F.-R., Iwasaki, A., Suenaga, K., Alajlani, M., Göransson, U., & El-Seedi, H. R.
- Affiliations
- Karolinska University Hospital (SE)
- University of Kalamoon (SY)
- Cairo University (EG)
- Fujian Agriculture and Forestry University (CN)
- Quaid-i-Azam University (PK)
- Johannes Gutenberg University Mainz (DE)
- Kuwait University (KW)
- Department of Chemistry, Faculty of Science, University of Kuwait, 13060 Safat, Kuwait
- University of Karachi (PK)
- Kaohsiung Medical University (TW)
- Keio University (JP)
- Uppsala University (SE)
- Jiangsu University (CN)
- Corresponding author
- El-Seedi, Hesham R.
- ORCID
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2019-08-23
- Volume
- 17
- Issue
- 9
- Pages
- 491
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC6780632
- OpenAlex
- W2969876208
- Semantic Scholar
- fc04613de468c55e3c00acaa04bbf85967f96088
- Cited by
- 555
- References
- 235
- Citations by year
- 2026: 32 · 2025: 73 · 2024: 100 · 2023: 88 · 2022: 109 · 2021: 98 · 2020: 49 · 2019: 4
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Uppsala University (Swedish Research links grant 2016-05885 (VR for the years 2017 - 2019))
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- marine natural products, anticancer agents, marine organisms, marine algae, marine bacteria, actinomycetes, marine fungi, marine sponges, soft coral, marine plants, apoptosis, cytotoxicity, cancer prevention, molecular mechanisms, bioactive metabolites, anticancer drug discovery
- MeSH terms
- Animals, Antineoplastic Agents, Biological Products, Clinical Trials as Topic, Disease Models, Animal, Humans, Neoplasms, Treatment Outcome, Aquatic Organisms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.